The efficacy of antihypertensive treatment in pregnant women with chronic and gestational hypertension: A population-based study

Hypertension Research

Volumn 33, Issue 5, 2010, Pages 460-466

  Bánhidy, Ferenc ^a   Cs, Nándor ^a   Puhó, Erzsébet H ^b   Czeizel, Andrew E ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b FOUNDATION FOR THE COMMUNITY CONTROL OF HEREDITARY DISEASES   (Hungary)

Author keywords

Antihypertensive drugs treatments; Chronic hypertension; Gestational hypertension; Low birthweight; Pregnancy complications

Indexed keywords

ANTIHYPERTENSIVE AGENT; BENCYCLANE; CAPTOPRIL; CHLORTALIDONE; CLOPAMIDE; DEBRISOQUINE; DIHYDRALAZINE; DROTAVERINE; FELODIPINE; FENOTEROL; FOLIC ACID; FUROSEMIDE; GUANETHIDINE; HYDROCHLOROTHIAZIDE; METHYLDOPA; METOPROLOL; MULTIVITAMIN; NICOTINIC ACID; NIFEDIPINE; OXPRENOLOL; PINDOLOL; POTASSIUM; PRAZOSIN; PROPRANOLOL; RESERPINE; RITODRINE; SPIRONOLACTONE; TERBUTALINE; UNINDEXED DRUG; VERAPAMIL;

ABORTION; ANEMIA; ANTEPARTUM HEMORRHAGE; ARTICLE; BIRTH ORDER; CHRONIC DISEASE; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HYPERTENSION; IMMINENT ABORTION; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; NAUSEA AND VOMITING; OUTCOME ASSESSMENT; PLACENTA DISORDER; PLACENTA PREVIA; POPULATION RESEARCH; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURITY; PRENATAL PERIOD; RISK FACTOR; SEX RATIO; SOLUTIO PLACENTAE;

ANTIHYPERTENSIVE AGENTS; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; FEMALE; HUMANS; HUNGARY; HYPERTENSION; HYPERTENSION, PREGNANCY-INDUCED; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; PREGNANCY; PREGNANCY OUTCOME; PREMATURE BIRTH; PRENATAL EXPOSURE DELAYED EFFECTS; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 77951965168     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2010.17     Document Type: Article

References (31)

1. Rashidi A, Rachman M, Wright JT. Diagnosis and treatment of hypertension. In: Fuster V, Walsh RA, O'Rourke RA, Poole-Wilson P (eds). Hurst's The Heart, 12th edn. McGraw Hill Medical: New York, NY, 2008, pp 1610-1629.
2. Rey E, LeLorier J, Burgess E, Lange IR, Leduc L. Report of the Canadian Hypertension Society Consensus Conference. 3. Pharmacologic treatment of hypertensive treatment in pregnancy. Can Med Assoc J 1997; 157: 1245-1254.
3. Churchill D. The new American guidelines on the hypertensive disorders of pregnancy. J Hum Hypertens 2001; 15: 583-585.
4. Gifford R, August P, Cunningham G, Green LA, Lindheimer MD, McNellis D, Roberts JM, Sibai BM, Taler SJ. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000; 183: S1-S15.
5. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright Jr JT, Roccella EJ, National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572. (Pubitemid 37430158)
6. Czeizel AE, Rockenbauer M, Siffel Cs, Varga E. Description and mission evaluation of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980-1996. Teratology 2001; 63: 176-185.
7. Czeizel AE. The first 25 years of the Hungarian Congenital Abnormality Registry. Teratology 1997; 55: 299-305.
8. Czeizel AE, Petik D, Vargha P. Validation studies of drug exposures in pregnant women. Pharmacoepidemiol Drug Saf 2003; 2: 409-416.
9. Czeizel AE, Vargha P. Periconceptional folic acid/multivitamin supplementation and twin pregnancy. Am J Obstet Gynecol 2004; 191: 790-794.
10. Hall JE, Granger JP, Hall ME, Jones DW. Pathophysiology of hypertension. In: Fuster V, Walsh RA, O'Rourke RA, Poole-Wilson P (eds). Hurst's The Heart, 12th edn. McGraw Hill Medical: New York, NY, 2008, pp 1570-1609.
11. Pickering TG, Ogedegbe G. Epidemiology of hypertension. In: Fuster V, Walsh RA, O'Rourke RA, Poole-Wilson P (eds). Hurst's The Heart, 12th edn. McGraw Hill Medical: New York, NY, 2008, pp 1551-1569.
12. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev, update, CD002252.
13. NHBPEWG. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000; 183: S1-S22.
14. Puho E, Métneki J, Czeizel AE. Maternal employment status and isolated orofacial clefts in Hungary. Cent Eur J Public Health 2005; 13: 144-148. (Pubitemid 41375082)
15. Massaro EJ, Rogers JM (eds). Folate and Human Development. Humana Press: Totawa, NJ, 2002.
16. Arias F, Zamora J. Antihypertensive treatment and pregnancy outcome in patients with mild chronic hypertension. Obstet Gynecol 1979; 53: 489-492.
17. Shepard TH, Lemire RJ. Catalog of Teratogenic Agents, 11th edn. Johns Hopkins University Press: Baltimore, 2004.
18. Ounsted M, Cockburn J, Moar VA, Redman CWl. Maternal hypertension with superimposed preeclampsia: Effects on child development at 7 1/2 years. Br J Obstet Gynecol 1983; 90: 644-650.
19. Sorensen HT, Czeizel AE, Rckenbauer M, Steffensen FH, Olsen J. The risk of limb deficiencies and other congenital abnormalities in children exposed in utero to calcium channel blockers. Acta Obstet Gynecol Scand 2001; 80: 379-401.
20. Hanssens M, Keirse MJ, Vankelecom F, Van Assche FA. Fetal and neonatal effects of treatment with angiotensin converting enzyme inhibitors in pregnancy. Obstet Gynecol 1991; 78: 128-135.
21. Lambot MA, Vermeylen D, Noel JC. Angiotensin-II-receptor inhibitors in pregnancy. Lancet 2001; 357: 1619-1620.
22. Czeizel AE, Petik D, Vargha P. Smoking and alcohol drinking during pregnancy. The reliability of retrospective maternal self-reported information. Cent Eur J Public Health 2004; 12: 179-183.
23. Rey E, Couturier A. The prognosis of pregnancy in women with chronic hypertension. Am J Obstet Gynecol 1994; 171: 410-415.
24. Tervila L, Goecke C, Timonen S. Estimation of gestosis of pregnancy (EPH-gestosis). Acta Obstet Gynecol Scand 1973; 52: 235-241.
25. Sibai BM, Mabie WC, Shamsa R, Villar MA, Anderson GD. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol 1990; 162: 960-967.
26. Buchbinder A, Sibai BM, Caritis S, MacPherson C, Hauth J, Lindheimer MD, Klebanoff M, Vandorsten P, Landon M, Paul R, Miodovnik M, Meis P, Thurnau G, National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol 2002; 186: 66-70.
27. Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E, VanDorsten P, Landon M, Paul R, Miodovnik M, Meis P, Thurnau G. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998; 338: 701-706.
28. Imperiale TF, Petrulis AS. A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease. JAMA 1991; 266: 461-466.
29. Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, Hester A, Gupte J, Gatlin M, Velazquez EJ, ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359: 2417-2428.
30. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Kjeldsen SE, Erdine S, Narkiewicz K, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Cifkova R, Dominiczak A, Fagard R, Heagerty AM, Laurent S, Lindholm LH, Mancia G, Manolis A, Nilsson PM, Redon J, Schmieder RE, Struijker-Boudier HA, Viigimaa M, Filippatos G, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Kiowski W, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Viigimaa M, Waeber B, Williams B, Zamorano JL, The task force for the management of arterial hypertension of the European Society of Hypertension, The task force for the management of arterial hypertension of the European Society of Cardiology. 2007 Guideline for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC). Eur Heart J 2007; 28: 1462-1536.
31. Chobanian AV. Does it matter how hypertension is controlled? N Engl J Med 2008; 359: 2485-2488.